ACTSI Investigator Dr. Walter Curran in the News
Walter Curran Jr., MD, ACTSI investigator, Lawrence W. Davis Professor and Chair of radiation oncology, and chief medical officer and executive director of Winship Cancer Institute, Emory University
Atlanta Business Chronicle | Curran runs Winship Cancer Institute
April 8, 2016
Winship News | Winship Executive Director Authors NEJM Study
April 6, 2016
Winship News | "Fashion a Cure" raises $170,000 for cancer research
March 2, 2016
Hem/Onc Today | Winship Cancer Institute appoints new deputy director
February 14, 2016
CNN | Is the cure for cancer real or rhetoric?
January 14, 2016
Emory Medicine | Caring for President Carter
Winter 2016
Gold Medalists to be Honored at ACR2016-The Crossroads of Radiology
October 28, 2015
Philly.com | Carter's cancer fight reflects change in treatment of elderly
August 26, 2015
Associated Press | Cancer forces Jimmy Carter to slow down but not stop work
August 24, 2015
Atlanta Journal-Constitution | Treating Jimmy Carter's cancer
August 24, 2015
Curran was appointed to serve on a new, seven-person advisory panel to NASA. The NASA Research and
Clinical Advisory Panel (RCAP) will advise NASA on research opportunities and priorities and finding decisions related to the national space and aeronautic programs.
New York Times | ABC News, Bloomberg, NBC News, CNN,NPR , Reuters, Wall Street Journal, Washington Post | Ailing Jimmy Carter 'at ease with whatever comes'
August 20, 2015
Video: Curran discusses proton therapy at ASCO 2015
Video: Curran previews Winship discoveries at ASCO 2015
MedPage Today | Oncologists weigh in on Ken Burns' cancer documentary
April 14, 2015
Winship Research Featured in New ASCO Annual Progress Report
Research studies from two Winship Cancer Institute experts are highlighted in the newly released Annual Report on Progress Against Cancer from the American Society of Clinical Oncology (ASCO). Curran is senior author of a paper featured in the report that shows survival is extended for certain patients with low grade brain tumors who are treated with a combination of chemotherapy and radiotherapy. The study, sponsored by the Radiation Therapy Oncology Group (RTOG, now under NRG
Oncology’s auspices), was presented at the 2014 ASCO Annual Meeting and published in abstract form in the Journal of Clinical Oncology (JCO). ASCO notes that combination therapy has proven “enormously effective against many types of cancer.”
MedPage Today | ASCO Oncologists: Why I tweet
June 5, 2014
Georgia Trend | Help and Hope: When it comes to finding a cure for childhood cancer, Georgia is leading the charge
April 2014
Health Imaging Hub | Adding bevacizumab to initial glibolastoma treatment does not improve overall survival
February 24, 2014
Medical News Today | Overall survival not improved by adding bevacizumab to initial glioblastoma treatment
February 21, 2014
Curran was elected in 2014 to a radiation oncologist seat on the American Society of Clinical Oncology board of directors.
CNN | WHO: Imminent global cancer 'disaster' reflects aging, lifestyle factors
February 4, 2014
Curran is listed as 19th among more than 35,000 researchers nationwide in a ranking of principal investigator recipients of NIH research dollars in 2013, according to the Blue Ridge Institute for Medical Research. Read more.
The Oncology Report | Sequester continuing to hit cancer research hard
December 4, 2013
WABE | Head of Emory's Winship Cancer Institute: Sequestration taking toll
December 4, 2013
Atlanta Business Chronicle | Winship's Curran named GRA Eminent Scholar
September 11, 2013
Emory News Center | Georgia Research Alliance names Winship Cancer Institute director a GRA Eminent Scholar
September 11, 2013
Atlanta Business Chronicle | Health-Care Quarterly Who's Who in Health Care: Celebrating Atlanta's top minds in health care
January 25, 2013